Furthermore, CCLE RNA-seq and quantitative proteomics data indicated inverse expression between FOXA1 and NR3C1 in several PCa, bladder, esophagus, and squamous lung cancer cell lines (Supplementary Figure S17). The gene discussed is FOXA1; the disease is posterior cortical atrophy.